NO752972L - - Google Patents
Info
- Publication number
- NO752972L NO752972L NO752972A NO752972A NO752972L NO 752972 L NO752972 L NO 752972L NO 752972 A NO752972 A NO 752972A NO 752972 A NO752972 A NO 752972A NO 752972 L NO752972 L NO 752972L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- formula
- carbon atoms
- residue
- stands
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 29
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 239000001257 hydrogen Substances 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 150000007513 acids Chemical class 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 3
- HONLKDDLTAZVQV-UHFFFAOYSA-N eburnamine Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)N5C2=C1 HONLKDDLTAZVQV-UHFFFAOYSA-N 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- 229950002496 vincanol Drugs 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims description 2
- HONLKDDLTAZVQV-UHOSZYNNSA-N vincanol Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@H](O)N5C2=C1 HONLKDDLTAZVQV-UHOSZYNNSA-N 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-M fumarate(1-) Chemical compound OC(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-M 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VKTOXAGUZWAECL-UHFFFAOYSA-N trans-eburnamenine Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)C=CN5C2=C1 VKTOXAGUZWAECL-UHFFFAOYSA-N 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- BVWWUWXMEWKEMC-UHFFFAOYSA-N O-methyleburnamine Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(OC)N5C2=C1 BVWWUWXMEWKEMC-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- -1 hydrogen halogen Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 208000009999 tuberous sclerosis Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1215374A CH602734A5 (en) | 1974-09-06 | 1974-09-06 | Vincanol derivs |
| CH711875A CH609984A5 (en) | 1975-06-03 | 1975-06-03 | Process for the preparation of novel compounds of the vincanol-epivincanol group |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO752972L true NO752972L (xx) | 1976-03-09 |
Family
ID=25700781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO752972A NO752972L (xx) | 1974-09-06 | 1975-08-29 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4045443A (xx) |
| JP (1) | JPS5154600A (xx) |
| AU (1) | AU8456775A (xx) |
| DD (1) | DD121943A5 (xx) |
| DE (1) | DE2538095A1 (xx) |
| DK (1) | DK388475A (xx) |
| ES (2) | ES440723A1 (xx) |
| FI (1) | FI752423A (xx) |
| FR (1) | FR2342065A1 (xx) |
| GB (1) | GB1518987A (xx) |
| IL (1) | IL48054A (xx) |
| NL (1) | NL7510315A (xx) |
| NO (1) | NO752972L (xx) |
| SE (1) | SE7509657L (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU173511B (hu) * | 1976-07-21 | 1979-05-28 | Richter Gedeon Vegyeszet | Sposob poluchenija vinkamenina, ego solejj i molekuljarnykh soedinenijj |
| FR2398746A1 (fr) * | 1977-07-25 | 1979-02-23 | Roussel Uclaf | Nouveaux derives d'alcaloides pentacycliques, leur procede de preparation, leur application comme medicaments, et leur application a la synthese de produits du groupe de l'eburnamonine |
| HU180929B (en) * | 1979-08-13 | 1983-05-30 | Richter Gedeon Vegyeszet | Process for producing new bromo-vincamone derivatives |
| JPS56161388A (en) | 1980-05-16 | 1981-12-11 | Nippon Zoki Pharmaceut Co Ltd | Novel vincamine derivative |
| JPS5732281A (en) * | 1980-08-06 | 1982-02-20 | Sumitomo Chem Co Ltd | Nitrogen-containing polycyclic compound and its preparation |
| FR2623501B1 (fr) * | 1987-11-19 | 1990-03-16 | Roussel Uclaf | Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
| FR2869034B1 (fr) * | 2004-04-14 | 2008-04-04 | Biocortech Soc Par Actions Sim | Derive du 14,15-dihydro 20,21-dinoreburnamenin 14-ol et leur utilisation pour le traitement des depressions |
-
1975
- 1975-08-27 DE DE19752538095 patent/DE2538095A1/de not_active Withdrawn
- 1975-08-28 FI FI752423A patent/FI752423A/fi not_active Application Discontinuation
- 1975-08-28 DK DK388475A patent/DK388475A/da unknown
- 1975-08-29 NO NO752972A patent/NO752972L/no unknown
- 1975-08-29 SE SE7509657A patent/SE7509657L/xx unknown
- 1975-09-02 NL NL7510315A patent/NL7510315A/xx not_active Application Discontinuation
- 1975-09-02 FR FR7526884A patent/FR2342065A1/fr active Granted
- 1975-09-02 US US05/609,357 patent/US4045443A/en not_active Expired - Lifetime
- 1975-09-03 GB GB36242/75A patent/GB1518987A/en not_active Expired
- 1975-09-04 DD DD188188A patent/DD121943A5/xx unknown
- 1975-09-04 IL IL48054A patent/IL48054A/xx unknown
- 1975-09-04 AU AU84567/75A patent/AU8456775A/en not_active Expired
- 1975-09-04 ES ES440723A patent/ES440723A1/es not_active Expired
- 1975-09-05 JP JP50107161A patent/JPS5154600A/ja active Pending
-
1977
- 1977-03-01 ES ES456416A patent/ES456416A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU8456775A (en) | 1977-03-10 |
| ES440723A1 (es) | 1977-07-01 |
| FR2342065B1 (xx) | 1978-09-08 |
| IL48054A (en) | 1978-09-29 |
| IL48054A0 (en) | 1975-11-25 |
| GB1518987A (en) | 1978-07-26 |
| NL7510315A (nl) | 1976-03-09 |
| DE2538095A1 (de) | 1976-03-25 |
| US4045443A (en) | 1977-08-30 |
| DK388475A (da) | 1976-03-07 |
| ES456416A1 (es) | 1978-06-16 |
| JPS5154600A (xx) | 1976-05-13 |
| FI752423A (xx) | 1976-03-07 |
| SE7509657L (sv) | 1976-03-08 |
| FR2342065A1 (fr) | 1977-09-23 |
| DD121943A5 (xx) | 1976-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7999106B2 (en) | Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form I | |
| US20090137797A1 (en) | Organic Compounds | |
| HU193161B (en) | Process for preparing new n-alkyl-norscopines | |
| MXPA01012237A (es) | Metodo para la produccion de tiazolidina. | |
| NO752972L (xx) | ||
| MXPA04008728A (es) | Procedimiento para producir derivados de acido trans-4-amino-1-ciclohexanocarboxilico. | |
| ES8504797A1 (es) | Procedimiento para la preparacion de nuevos derivados de hidroxiimino-octahidro-indolo(2,3-a)quinolizina | |
| NO752493L (xx) | ||
| KR100913684B1 (ko) | Ｒ-티옥트산의 트로메타몰 염의 신규한 결정체, 이의 제조방법 및 이를 포함하는 약제 | |
| NO128533B (xx) | ||
| JPS6249261B2 (xx) | ||
| JPH02188570A (ja) | ハロゲン置換キノリン誘導体の製造法 | |
| EP3805244A1 (en) | Synthesis of glycoconjugate derivatives of a bile acid | |
| JP2005502651A (ja) | 高純度セフロキシムアキセチルの製造方法 | |
| HU193632B (en) | Process for producing alpha-halogeno-alkylamide | |
| NO762489L (xx) | ||
| US20040053967A1 (en) | 3-(3-Amidinophenyl)-5-[({[1-(1-(iminoethyl)-4-piperidyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same | |
| JP4000113B2 (ja) | （３ｓ）−３−メトキシカルボニル−４−フェニル酪酸金属塩およびその使用方法 | |
| US4123535A (en) | Psychostimulating 14-amino-14,15-dihydroeburnamenines | |
| JPH07278156A (ja) | ジメチルアミン−ボランの製造方法 | |
| JPH04169583A (ja) | フェノチアジン誘導体およびその製造方法 | |
| US3308132A (en) | 6, 8-dithiooctanoyl amides and intermediates | |
| US3842086A (en) | Process for the preparation of substituted or unsubstituted pyridines | |
| JPS6339893A (ja) | ５−フルオロウリジン類およびその製法 | |
| JPH10287650A (ja) | １−クロロカルボニル−４−ピペリジノピペリジンまたはその塩酸塩の製造方法 |